This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: Teruo Hashimoto: Innovator in Pharmaceutical Chemistry
Introduction
Teruo Hashimoto is a notable inventor based in Hiromachi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of cephalosporin derivatives. His work has implications for the production of important pharmaceuticals.
Latest Patents
Hashimoto holds a patent for a process for preparing cephalosporin derivatives. This innovative method involves heating specific compounds under controlled conditions to minimize water presence. The resulting compounds are valuable as pharmaceuticals or intermediates in pharmaceutical production. One notable compound he developed is 7.alpha.-methoxy-3-(1-methyl-1H-tetrazol-5-yl)thiomethyl-7.beta.-(O-5-p-nitrobenzoylamino-5-carboxyvaleramido-3-cephem-4-carboxylic acid), which is recognized as a new compound with potential pharmaceutical applications.
Career Highlights
Hashimoto is associated with Sankyo Company, Limited, where he has contributed to various research initiatives. His work has led to advancements in the pharmaceutical industry, particularly in antibiotic development.
Collaborations
Throughout his career, Hashimoto has collaborated with esteemed colleagues such as Junichi Nakazawa and Masanao Kaneko. These collaborations have further enriched his research and innovation in the field.
Conclusion
Teruo Hashimoto's contributions to pharmaceutical chemistry, particularly through his patented processes, highlight his role as an influential inventor. His work continues to impact the development of essential pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
